Ignite Creation Date:
2024-07-17 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06466525
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-10
Brief Title:
A Two-Part Single and Multiple Ascending Dose Trial of the Safety Tolerability Pharmacokinetics and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinsons Disease
Sponsor:
Longevity Biotech Australia Pty Ltd subsidiary
Organization:
Longevity Biotech
Organization Data
Organization:
Longevity Biotech
Class:
INDUSTRY
Study ID:
LBT-3627-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Longevity Biotech Australia Pty Ltd subsidiary
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None